ArticleCureus2025
High Prolactin and Anemia as Factors in Female Infertility: A Cross-Sectional Study in Infertile Women of Balochistan, Pakistan.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prolactin as an immuno-neuroendocrine integrator: linking immune homeostasis, hematopoietic dynamics and iron metabolism.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Female infertility is a significant health challenge, with hormonal imbalances and nutritional deficiencies being among the key contributing factors. Both hyperprolactinemia and anemia have been suggested as potential factors affecting fertility in women. Objective This study aims to determine the prolactin levels and anemia prevalence in infertile women of Balochistan, Pakistan, and to establish whether female infertility is related to hyperprolactinemia and anemia, in addition to the association between hyperprolactinemia and anemia in infertile women. Methods This cross-sectional research was conducted in the Department of Obstetrics and Gynecology at Mekran Medical College, Turbat, Balochistan, from January 2024 to June 2024. A total of 310 women diagnosed with infertility were divided into two groups: 222 women with primary infertility and 88 women with secondary infertility. The study participants' prolactin levels were measured, and the prevalence of anemia was determined by measuring hemoglobin levels. Results Of the primary infertile women, 148 (47.7%) participants had hyperprolactinemia, whereas 38 (12.3%) secondary infertile women had hyperprolactinemia. The mean serum prolactin levels were significantly higher in primary infertility patients compared to secondary infertility patients (31.85 ± 29.46 ng/mL versus 22.97 ± 18.24 ng/mL, p = 0.009). A p-value of <0.05 (p = 0.001) showed a statistically significant association between infertility type and prolactin levels, with primary infertility showing a higher prevalence of raised prolactin compared to secondary infertility. Mean hemoglobin levels were significantly lower in primary infertility patients (11.58 ± 1.53 g/dL versus 12.14 ± 1.48 g/dL, p = 0.019), with 113 (50.9%) of primary infertile women having anemia compared to 54 (61.4%) of secondary infertile women. In total, 167 (53.8%) infertile women had anemia. Secondary infertility showed a higher prevalence of anemia than primary infertility. However, no statistically significant association existed between prolactin levels and anemia in different infertility types. Conclusion Our study shows that the high occurrence of anemia and increased prolactin levels in women of reproductive age suggest their contributory role in causing infertility. Regular screening and prompt intervention for anemia and hyperprolactinemia are critical in treating infertility-related outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.